SearchInput the word you want to find
- ABOUT JSMO
- HOME
- ABOUT JSMO
- 2024 Award Recipients
2024 Award Recipients
2024 Award Recipients
| Annals of Oncology Award | ||
|---|---|---|
| Name | Affiliation | Affiliation |
| Kentaro Yamazaki | Division of Gastrointestinal Oncology, Shizuoka Cancer Center |
Oxaliplatin-based adjuvant chemotherapy duration (3 versus 6 months) for high-risk stage II colon cancer: the randomized phase III ACHIEVE-2 trial https://www.sciencedirect.com/science/article/pii/S0923753420429837 |
| Young Investigator Award | ||
| Name | Affiliation | Title |
| Keisuke Koroki | Department of Gastroenterology, Graduate School of Medicine, Chiba University |
Phase Ib trial of durvalumab plus tremelimumab with particle therapy in HCC with macrovascular invasion: DEPARTURE trial |
| Tadayoshi Hashimoto | Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East |
The utility of circulating tumor DNA in gastrointestinal stromal tumor -a pooled analysis of SCRUM-Japan trials- |
| Daichi Fujimoto | Internal Medicine III, Wakayama Medical University |
Prediction of prognosis in stage 4 lung cancer using machine learning:A multicenter cohort study (WJOG15121L:REAL-WIND) |
| Keiichiro Mori | Department of Urology, The Jikei University School of Medicine |
Catalog of preoperative blood-based biomarkers in patients treated with radical cystectomy for bladder carcinoma |
| Kakuhiro Yamaguchi | Hiroshima University Hospital, Departement of Respiratory Medicine |
Prospective observational study to identify a predictive blood marker for checkpoint inhibitor pneumonitis (CS-Lung 004) |
| Kyoko Yamaguchi | Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital |
Efficacy of Pembrolizumab in metastatic colorectal cancer with TMB-High/non-MSI-high |
| Se Ik Kim | Department of Obsetetrics and Gynecology, Seoul National University College of Medicine |
Predicting therapeutic response to PARP inhibitors in high-grade serous ovarian cancer: A Comprehensive proteomics study |
| Yung-Yeh Su | National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan |
Chemoradiation Augments Gemcitabine in HRD-Positive Pancreatic Cancer: Results from A Randomized Adjuvant Trial |
| Wan-Ming Chen | Graduate Institute of Business Administration, College of Management, Fu Jen Catholic University, Taipei, Taiwan |
Effects of SGLT2 Inhibitors on Clinical Cancer Survival |
※Titles omitted, listed in Japanese alphabetical order.
※Affiliations are listed as of the time of the award.
Scenes from the Award Ceremony
※Click to view a larger image.
©Japanese Society of Medical Oncology All rights reserved.